IRIS
PREVITI, Santo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.393
NA - Nord America 2.678
AS - Asia 1.565
SA - Sud America 492
Continente sconosciuto - Info sul continente non disponibili 332
AF - Africa 52
OC - Oceania 4
Totale 8.516
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.547
RU - Federazione Russa 1.769
SG - Singapore 640
IT - Italia 515
BR - Brasile 412
CN - Cina 408
IE - Irlanda 300
HK - Hong Kong 217
SE - Svezia 180
PL - Polonia 179
FR - Francia 111
VN - Vietnam 111
DE - Germania 84
AT - Austria 71
GB - Regno Unito 61
CA - Canada 53
IN - India 37
MX - Messico 36
BE - Belgio 35
AR - Argentina 27
BD - Bangladesh 23
FI - Finlandia 23
IQ - Iraq 23
NL - Olanda 19
MA - Marocco 15
ID - Indonesia 14
TR - Turchia 14
CO - Colombia 13
UZ - Uzbekistan 12
PK - Pakistan 11
ZA - Sudafrica 11
EC - Ecuador 10
UA - Ucraina 10
VE - Venezuela 10
ES - Italia 8
CR - Costa Rica 7
PY - Paraguay 7
JP - Giappone 6
MY - Malesia 6
PR - Porto Rico 6
SA - Arabia Saudita 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
DZ - Algeria 5
HN - Honduras 5
LT - Lituania 5
TN - Tunisia 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
KE - Kenya 4
NI - Nicaragua 4
PE - Perù 4
SV - El Salvador 4
AU - Australia 3
GE - Georgia 3
KR - Corea 3
KW - Kuwait 3
LB - Libano 3
PH - Filippine 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CH - Svizzera 2
CI - Costa d'Avorio 2
EG - Egitto 2
GR - Grecia 2
GT - Guatemala 2
IR - Iran 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
RS - Serbia 2
SY - Repubblica araba siriana 2
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GD - Grenada 1
GP - Guadalupe 1
IL - Israele 1
KN - Saint Kitts e Nevis 1
LY - Libia 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
RO - Romania 1
SC - Seychelles 1
SN - Senegal 1
Totale 8.184
Salva come PNG Salva come JPEG
Città #
Moscow 538
Ashburn 387
Singapore 355
Dublin 300
Chandler 251
Hong Kong 217
Warsaw 176
San Jose 163
Messina 162
Nyköping 148
Beijing 128
Dallas 127
Council Bluffs 112
Vienna 62
Los Angeles 50
Princeton 50
Santa Clara 40
Ann Arbor 38
Lauterbourg 38
The Dalles 38
Ho Chi Minh City 35
Medford 34
Redondo Beach 33
Des Moines 31
Rome 28
São Paulo 26
Guangzhou 24
Hanoi 24
New York 24
Frankfurt am Main 21
Houston 21
Brussels 20
Jacksonville 20
Aversa 19
Montreal 18
Brasília 17
Orem 17
Buffalo 16
Dearborn 16
Montpellier 16
Munich 16
Cambridge 14
Mexico City 14
Modica 14
Bari 13
San Mateo 13
Naples 12
San Francisco 12
Tashkent 12
Tianjin 12
Amsterdam 11
Atlanta 11
Baghdad 11
Belo Horizonte 10
Catania 10
Chennai 10
Milan 10
Phoenix 10
Rio de Janeiro 10
Shenzhen 10
Boston 9
Brooklyn 9
Chicago 9
Curitiba 9
Denver 9
Jinan 9
London 9
Wilmington 9
Ixelles-Elsene 8
Stockholm 8
Bexley 7
Boardman 7
Columbus 7
Helsinki 7
Seattle 7
Siderno 7
Berlin 6
Campinas 6
Francavilla di Sicilia 6
Goiânia 6
Haikou 6
Medellín 6
Nuremberg 6
Portsmouth 6
Querétaro 6
Shanghai 6
Shenyang 6
Taizhou 6
Tokyo 6
Biên Hòa 5
Florence 5
Francofonte 5
Istanbul 5
Johannesburg 5
Lawrenceville 5
Manchester 5
Milwaukee 5
North Bergen 5
Poplar 5
Porto Alegre 5
Totale 4.338
Salva come PNG Salva come JPEG
Nome #
Design, synthesis and biological evaluation of novel inhibitors of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense, as antitrypanosomal agents 354
Development of novel Michael acceptors targeting rhodesain as antitrypanosomal agents 208
Design, synthesis and biological evaluation of novel rhodesain inhibitors for the treatment of Human African Trypanosomiasis 199
Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors 193
Drug combination studies of isoquinolinone AM12 with curcumin or quercetin: a new combination strategy to synergistically inhibit 20S proteasome 177
Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain 174
Design, synthesis and biological evaluation of novel dipeptide-like rhodesain inhibitors containing a conformationally constrained 3-bromoisoxazoline warhead 174
Design and NMR conformational analysis in solution of β5i-selective inhibitors of immunoproteasome 168
Development of novel 1,4-benzodiazepine-based Michael acceptors as antitrypanosomal agents 168
Synthesis and biological evaluation of novel peptidomimetics as rhodesain inhibitors 167
Development of novel irreversible rhodesain inhibitors as antitrypanosomal agents. 160
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 160
Design and evaluation of non-carboxylate 5-arylidene-2-thioxo-4-imidazolidinones as novel non-competitive inhibitors of protein tyrosine phosphatase 1B 160
Development of novel amides as non covalent inhibitors of immunoproteasome 159
Evaluation of curcumin irreversibility 157
Development of novel benzodiazepine-based peptidomimetics as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 156
Drug combination studies of curcumin and genistein against rhodesain of Trypanosoma brucei rhodesiense 154
Immunoproteasome-selective inhibitors: a promising strategy to treat hematologic malignancies, autoimmune and inflammatory diseases 149
Development of novel 1,4-benzodiazepines as antitrypanosomal agents 148
Discovery of novel peptidomimetics containing a benzodiazepine scaffold as inhibitors of rhodesain of Trypanosoma brucei rhodesiense 148
Development of novel dipeptide nitriles as inhibitors of rhodesain of Trypanosoma brucei hodesiense 144
Optimization Strategy of Novel Peptide-Based Michael Acceptors for the Treatment of Human African Trypanosomiasis 142
Development of isoquinolinone derivatives as immunoproteasome inhibitors. 140
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 137
Design, synthesis and biological evaluation of potent rhodesain inhibitors as antitrypanosomal agents 136
A second opportunity for the peptide-based analogues with γ-lactam at the P1 position: human cathepsin S inhibition 133
Development of Novel Benzodiazepine-Based Peptidomimetics as Inhibitors of Rhodesain from Trypanosoma brucei rhodesiense 133
The Inhibition of Cysteine Proteases Rhodesain and TbCatB: A Valuable Approach to Treat Human African Trypanosomiasis 130
Development of Novel Peptide-based Michael Acceptors Targeting Rhodesain and Falcipain-2 for the Treatment of Neglected Tropical Diseases (NTDs) 130
Development of novel dipeptide-like rhodesain inhibitors containing the 3-bromoisoxazoline warhead in a constrained conformation 130
Monoclonal antibodies: the greatest resource to treat multiple myeloma 129
Development of novel peptidyl nitriles targeting rhodesain and falcipain-2 for the treatment of sleeping sickness and malaria 125
Development of peptidyl Michael acceptors for S3 pocket investigation of rhodesain, cysteine protease of Trypanosoma brucei rhodesiense 125
Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors 124
Development of reduced peptide bond pseudopeptide Michael acceptors for the treatment of Human African Trypanosomiasis 123
Development of novel peptide-based Michael acceptors targeting rhodesain and falcipain-2 for the treatment of neglected tropical diseases (NTDs) 121
Dipeptide nitrile CD34 with curcumin: a new improved combination strategy to synergistically inhibit rhodesain of Trypanosoma brucei rhodesiense 121
Silicon-containing neurotensin analogues as radiopharmaceuticals for NTS1-positive tumors imaging 111
Peptidyl Vinyl Ketone Irreversible Inhibitors of Rhodesain: Modifications of the P2 Fragment 110
Falcipain-2 and Falcipain-3 inhibitors as promising antimalarial agents 103
Drug synergism: studies of combination of RK-52 and curcumin against rhodesain of Trypanosoma brucei rhodesiense 102
Neurotensin, a multi-faceted peptide 102
Lead discovery of SARS-CoV-2 main protease inhibitors through covalent docking-based virtual screening 101
Drug combination studies of PS-1 and quercetin against rhodesain of Trypanosoma brucei rhodesiense 99
Drug combination studies of the dipeptide nitrile CD24 with curcumin: a new strategy to synergistically inhibit rhodesain of trypanosoma brucei rhodesiense 98
CAR-T cell therapy for prostate cancer: current advances and future perspectives 97
Optimization of radiopharmaceuticals based on neurotensin[8-13] for NTS1-positive tumours imaging 97
Design, synthesis, and in vitro characterization of proteolytically-stable opioid-neurotensin hybrid peptidomimetics 96
Development of novel peptide-based Michael acceptors targeting rhodesain for the treatment of human african trypanosomiasis 94
The inhibition of NS2B/NS3 protease: a new therapeutic opportunity to treat Dengue and Zika virus infection 91
Design and synthesis of opioid-neurotensin hybrid peptidomimetics: analgesics with reduced side effect profiles 91
Optimized opioid-neurotensin multitarget peptides: from design to structure−activity relationship studies 90
Structure-based design of melanocortin 4 receptor ligands based on the SHU-9119-hMC4R cocrystal structure 90
Identification of dual inhibitors targeting main protease (Mpro) and cathepsin L as potential anti-SARS-CoV‑2 agents 87
Identification of constrained peptidomimetics carrying a Michael acceptor warhead as antitrypanosomal agents 86
Design, synthesis, and biological evaluation of the first radio-metalated neurotensin analogue targeting neurotensin receptor 2 84
Design and synthesis of 68Ga-labeled peptide-based heterodimers for dual targeting of NTS1 and GRPR 78
Development of peptide-based SARS CoV-2 Mpro/hCatL dual inhibitors as antiviral agents 71
Dual inhibition of parasitic targets: a valuable strategy to treat malaria and neglected tropical diseases 67
Synthesis and Combination Studies of Novel Dipeptide Nitriles with Curcumin for a Potent Synergistic Action Against Rhodesain, Cysteine Protease of Trypanosoma brucei rhodesiense 62
Insightful backbone modifications preventing proteolytic degradation of neurotensin analogs improve NTS1-induced protective hypothermia 62
The role of nutraceuticals in chemoprevention and their therapeutic effects when used in combination with synthetic drugs 60
The Role of Nutraceuticals in Age-Related Ocular Diseases 52
null 50
Metabolically stable neurotensin analogs exert potent and long-acting analgesia without hypothermia 47
Selected Nutraceuticals in Metabolic Syndrome: Molecular Mechanisms and Clinical Implications 44
Influence of amino acid size at the P3 position of N-Cbz-tripeptide Michael acceptors targeting falcipain-2 and rhodesain for the treatment of malaria and human african trypanosomiasis 35
Rational design of NT-PSMA heterobivalent probes for prostate cancer theranostics 34
N-Terminal stabilization of radiolabeled neurotensin analogues for improved tumor uptake 31
Development of Novel Proline- and Pipecolic Acid-Based Allosteric Inhibitors of Dengue and Zika Virus NS2B/NS3 Protease 30
Opening the amino acid toolbox for peptide-based NTS2-selective ligands as promising lead compounds for pain management 30
Hybrid synthetic approach and biological characterization of a branched heterodimer for overcoming prostate cancer heterogeneity 30
Macrocycles and stapled-peptides in the fight against SARS-CoV-2: a review 29
null 28
null 22
null 22
Supplement: 37th European Peptide Symposium 14th International Peptide Symposium August 25–August 29, 2024 | Florence, Italy 18
Inhibitors of proteases: a well-grounded strategy in drug development 18
Synthesis of New Asymmetrical Chalcones and Evaluation of Their Use in Combination with Curcumin Against Rhodesain of T. brucei rhodesiense 11
Totale 8.516
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.372
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022233 0 0 0 0 9 7 44 8 3 20 20 122
2022/2023981 62 94 42 77 55 103 47 78 364 4 48 7
2023/2024319 43 47 18 60 45 11 7 6 2 29 33 18
2024/20251.182 30 9 23 94 41 22 76 195 272 80 129 211
2025/20264.051 162 209 231 290 336 846 547 497 530 215 70 118
2026/2027897 90 270 244 291 2 0 0 0 0 0 0 0
Totale 8.516